REQUEST A DEMO
Total
USD $0.00
Search more companies

Onkologiczna Pracownia Molekularna Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Ambulatory Health Care Services
Full name: Onkologiczna Pracownia Molekularna Sp. z o.o. Profile Updated: October 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Onkologiczna Pracownia Molekularna Sp. z o.o. is based in Poland. The head office is in Olsztyn. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was established on April 29, 2008. There are currently 5 (2009) people employed by Onkologiczna Pracownia Molekularna Sp. z o.o.. In its most recent financial highlights, the company reported a net sales revenue drop of 70.72% in 2023. There was a total negative growth of 29.82% in Onkologiczna Pracownia Molekularna Sp. z o.o.’s total assets over the same period. In 2023, Onkologiczna Pracownia Molekularna Sp. z o.o.’s net profit margin decreased by 119.9%.

Headquarters
Ul. Kardynala Stefana Wyszynskiego 1
Olsztyn; Warminsko-Mazurskie; Postal Code: 10-457

Contact Details: Purchase the Onkologiczna Pracownia Molekularna Sp. z o.o. report to view the information.

Website: http://www.poliklinika.olsztyn.pl

Basic Information
Total Employees:
Purchase the Onkologiczna Pracownia Molekularna Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Onkologiczna Pracownia Molekularna Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Onkologiczna Pracownia Molekularna Sp. z o.o. report to view the information.
Incorporation Date:
April 29, 2008
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Onkologiczna Pracownia Molekularna Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-70.72%
Total operating revenue
-54.21%
Operating profit (EBIT)
45.67%
EBITDA
53.25%
Net Profit (Loss) for the Period
42.87%
Total assets
-29.82%
Total equity
-78.88%
Operating Profit Margin (ROS)
-105.32%
Net Profit Margin
-119.9%
Return on Equity (ROE)
-235.45%
Debt to Equity Ratio
134.77%
Quick Ratio
-0.06%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?